Business

March 27, 2014

BioDelivery Sciences partners with Quintiles for anticipated drug launch

BioDelivery Sciences International announced Thursday that it has entered into an agreement with Quintiles to have it support the anticipated launch of Bunavail, BioDelivery Sciences treatment for opioid dependence.

Related content

Comments

Editor's Choice Videos